过氧化物酶体增殖物激活受体与代谢综合征

Peroxisome Proliferator Activated Receptor-γ(PPARγ) and Metabolic Syndrome

下载PDF

导出

摘要 PPARγ是一种由配体激活的核转录因子 ,对体内糖、脂肪代谢具有重要影响 ,并参与调节炎症、细胞凋亡、平滑肌迁移、增殖与动脉粥样硬化等病理过程。

作者林先和李隆贵

机构地区第三军医大学新桥医院心血管内科

出处《心血管病学进展》 CAS 2004年第2期132-135,共4页 Advances in Cardiovascular Diseases

关键词过氧化物酶体增殖物激活受体代谢综合征核转录因子发病机制治疗

参考文献29

1[1]Berger J,Moller DE. The mechanisms of action of PPARS[J]. Annu Rev Med, 2002,339:953-959.
2[2]Beamer BA,Negri C,Yen CJ, et al. Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-γ (hPPARγ) gene[J]. Biochem Biophys Res Commun,1997,233:756-759.
3[3]Hsu MH,palmer CNA,Song W,et al.A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator- activated receptor DNA binding[J]. J Biol Chem, 1998,273:27988-27997.
4[4]Desvergne B,Wahli W. Peroxisome proliferator-activated receptors:nuclear control of metabolism[J]. Endocr Rev,1999,20(5):649-689.
5[5]Olefsky JM.Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists[J]. J Clin Invest,2000,106(4):467-472.
6[6]Vamecq J,Latruffe N.Medical significance of peroxisome proliferator-activated receptors[J]. Lancet,1999,354(10):141-148.
7[7]Ramos F,Baglivo HP,Ramirez AJ,The metabolic syndrome and related cardiovascular risk[J]. Curr Hypertens Rep,2001,3(2):100-106.
8[8]Stumvoll M,Haring H.Insulin resistance and insulin sensitizers[J].Horm Res.2001,55(suppl 2):3-13.
9[9]Taylor,SI.Deconstructing type 2 diabetes[J].Cell,1999.97:9-12.
10[10]Patel NG,Holder JC,Smith SA,et al.Differential regulation of lipogenesis and leptin production by independent signaling pathways and rosiglitazone during human adipocyte differentiation[J]. Diabetes,2003,52(1):43-50.

心血管病学进展

2004年第2期

内容加载中请稍等...